Cardiosense
AI-enabled non-invasive cardiac monitoring company developing wearable technology for early detection and management of congestive heart failure.
Website
https://www.cardiosense.comLocation
Chicago, Illinois, USA
Founded
2016
Investors
1
Categories
digital-health, cardiology, cardiovascular, ai, medical-devices, wearables
Notes
Cardiosense is a clinical-stage digital health company developing AI-powered wearable technology for non-invasive cardiac monitoring, particularly focused on congestive heart failure. The company's technology enables early detection of heart failure decompensation, allowing for proactive intervention before patients require hospitalization.
Cardiosense spun out of research from Georgia Tech University and Northwestern University, combining expertise in biomedical engineering and artificial intelligence.
Team
- Amit Gupta - Founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/amitgupta
- Omer Inan, Ph.D. - Co-founder (Georgia Tech)
Additional Research Findings
- Portfolio company of Portal Innovations
- Stage: Clinical
- University Spinout: Georgia Tech University, Northwestern University
- Focus on heart failure monitoring and early intervention
- AI-enabled wearable cardiac monitoring technology
- Non-invasive approach to heart failure management
- Headquarters in Chicago, Illinois
- Developing solutions for remote patient monitoring
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Portal Innovations | US | biotech-focused | - | 13 |